Rock Springs Capital Management LP Xilio Therapeutics, Inc. Transaction History
Rock Springs Capital Management LP
- $2.94 Billion
- Q3 2024
A detailed history of Rock Springs Capital Management LP transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 3,003,259 shares of XLO stock, worth $2.64 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,003,259
Previous 3,003,259
-0.0%
Holding current value
$2.64 Million
Previous $2.85 Million
16.86%
% of portfolio
0.08%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding XLO
# of Institutions
34Shares Held
14MCall Options Held
0Put Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA4.57MShares$4.02 Million0.65% of portfolio
-
Morgan Stanley New York, NY1.52MShares$1.34 Million0.0% of portfolio
-
River Vest Venture Management LLC St. Louis, MO1.44MShares$1.27 Million16.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA903KShares$794,2270.0% of portfolio
-
Aju Ib Investment Co., Ltd. Seoul, M5668KShares$587,6123.33% of portfolio
About Xilio Therapeutics, Inc.
- Ticker XLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,471,600
- Market Cap $24.2M
- Description
- Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...